Stock Market Corrections | Stock Market Video

WONDA® Copyright © 2015 William O’Neil + Co., Inc. All rights reserved. Unauthorized duplication, modification, photocopying or distribution in any form is strictly prohibited.

In this week's Stock Market Video, Cabot China & Emerging Markets Report Editor Paul Goodwin talks about the market’s two-day swoon this week, seeing it as something to take note of, but not something to cause you to head for the bomb shelter. Stocks discussed: Hertz (HTZ), Lazard (LAZ), Medicines Company (MDCO), Qihoo 360 (QIHU), Cree (CREE), Oshkosh (OSK) and Lennar (LEN).

---

Double Your Money with Cabot China & Emerging Markets Report

Dear Fellow Investor,

When I'm talking to people about investing in emerging market stocks, I'm always aware that I have two choices. The first is to spout statistics:

*    About China's 1.3 billion people
*    The build-out of Internet access
*    The rising power of the Chinese consumer
*    The country's decade of double-digit economic growth
*    Colossal investment in infrastructure.

There's no doubt that these are impressive factors, and they certainly point to a national economy that's in high gear. But I don't think they tell the whole story.

If a growing economy automatically produced stock market gains, an investor's job would be very simple. You could just buy an ETF for that country and watch the money roll in.

But stock markets are too complex to reward that strategy, as investors are always looking ahead by six months or so. And just drawing a straight line that extends the current trend is almost sure to miss the mark.

As the emerging markets develop, their economies often rocket ahead, lifted by industrialization, urbanization, entrepreneurship and foreign direct investment. 

And the stocks of the companies doing business in these countries can blast off right along with them. This is what investors in Baidu (BIDU), China Mobile (CHL) and Ctrip.com (CTRP) found out a few years ago.

That's when Cabot China & Emerging Markets Report beat all investment advisories hands-down, doubling readers' retirement money four times in seven years.  

Just last year:…

Our top auto stock was up 127% in four months.
Our top entertainment stock was up 113% in 10 months.
Our top Internet stock was up 106% in six months.
Our top social networking stock was up 115% in five months.

And our China stocks continue to out perform the market!

Our instant messaging stock is up 25% in three months.
Our Amazon-like online retail stock is up 36% in three months.
Our flash sale online retail stock is up 35% in two months.
Our online games stock is up 23% in one month.

All while our entire portfolio is up 42% since the beginning of the year!

So don't wait. Click here to learn more on how Cabot China & Emerging Markets Report picks can be a great addition to your portfolio. Get your risk-free trial subscription today.

Order Now Learn More


Sincerely,

Paul Goodwin Signature

Paul Goodwin

Editor, Cabot China & Emerging Markets Report

Paul Goodwin Paul Goodwin 
Emerging Markets Specialist, Analyst and Editor of Cabot China & Emerging Markets Report

A researcher and writer for over 30 years, Paul Goodwin has been a member of the Cabot investment team and editor of Cabot China & Emerging Markets Report since 2005. Under Paul’s stewardship, Hulbert Financial Digest rated Cabot China & Emerging Markets Report the #1-rated newsletter of 2006 with a 78.6% gain for the year, and the #1-rated newsletter of 2007 with a  74.1% return. Cabot China & Emerging Markets Report was also named 2007 Investment Letter of the Year by Peter Brimelow of MarketWatch

Stock Picks

Ross Stores

McKesson (MCK) distributes ethical and proprietary drugs, surgical supplies and health and beauty products throughout North America to the healthcare industry. The company also provides technical consulting services to biotech and pharmaceutical manufacturers.

Carnival Cruise Lines

Having just returned from vacation, Tim Lutts is thinking of the millions of baby-boomers who are spending more and more money on leisure travel, particularly on cruises, an industry that is dominated by a few big players.

China Biologic Products

Paul Goodwin advises putting this stock on your watch list.

Cabot Wealth Advisory

Beach Weather in the Market

By Paul Goodwin on July 31, 2015

It’s the beginning of August, high summer in New England, and a bit of summer fatigue is setting in. Summer in New England is short, so we try to pack half a year’s worth of cookouts, beach days, hikes, kayaking, sight-seeing and other outside recreation into three months. It’s fun, but the pace can be a bit frantic, especially as the season enters its third act. Frankly, all I want to do now is lie on a beach somewhere and read a book. Read More >

Managing Your Stock Portfolio to the Market's Tune

By Michael Cintolo on July 30, 2015

In today’s Wealth Advisory, I’m doing something I’ve never done before—reprinting an entire piece I wrote in Cabot Growth Investor last Wednesday. It doesn’t involve any specific stock advice (that is and always will be for subscribers only), but it details the wild divergences in the market (which are now getting lots of press—even the Wall Street Journal had a big write-up on it Monday), what it means, and how I’m advising people to handle it—I think it’s very timely.Read More >

Do Your Stocks Have Borrowing Trouble?

By Nancy Zambell on July 28, 2015

Hostess is making news today as it is issuing $1.23 million in term loans—most of which will go toward paying $905 million in a special dividend to its private shareholders—which I may add, is also more than two times what the buyers paid for this tasty snack business, and triples the company’s debt. According to Bloomberg, these types of deals grew to nearly $16 billion in the second quarter, the highest level in the past 12 months. I’m not making a judgment for or against this action. I just want to make a point that this debt, or leverage recapitalization—spurred by low interest rates—is increasingly becoming a method in which private equity holders get their money back—without selling the business. But it does burden the company with additional debt, which isn’t going to fund company expansion or operations.Read More >